Ru 486 Misconceptions Myths and Morals - ressourcesfeministes

More documents

Recommendations

Info

EndnotesAnother such example is the outcome of prostaglandininteractions with lymphocytes (the white blood cells responsiblefor immune protection) where dosage manipulations permit theinduction of either immunosuppression or immunostimulation.Taken together with the variation in individual sensitivity toprostaglandins, the contradictory effects of both exogenous andendogenous prostaglandins are further evidence that RU 486/PG abortion methods should be resisted.4The type of prostaglandin analogue, its dose, administration siteand infusion time, and the number of previous pregnancies, areeach factors which contribute to the abortion-rate in prostaglandininducedterminations.5The guinea pig model was also crucial to the discovery ofsulprostone, which had very little activity in the rat model. I tstherapeutic potential would not have been recognized, but forguinea-pig studies which identified ‘E-prostaglandins to be morepotent abortifacients than F-prostaglandins’ (Elger et al., 1987:79).Subsequent studies in the guinea-pig model indicated the followingascending order of abortifacient activity: PGF 2•, PGE 2, PGE 1,sulprostone/15-methyl-PGF 2•and 16,16-dimethyl-PGE 2whichparalleled to a considerable extent the order of effectivenessobserved in human pregnancy.6K.Schmidt-Gollwitzer from Schering Gynecological Therapyreplied to our questions of 22 January 1991 with the followingstatement: ‘We are conducting research on and developing antiprogestinsubstances for the treatment of illnesses such as breastcancer or endometriosis. The substances presently underdevelopment are not intended for the indication of abortion’(pers. comm. to LD and RK, 19 March 1991).131
RU 486BIBLIOGRAPHYABC Nightly News Special Report with Peter Jennings. (1990). 29November, USA.Altman, Lawrence K. (1991, 9 April). A simpler way to employ RU498 is reported. New York Times: C3American Men and Women in Science. (1976). Thirteenth edition.R.R.Bawker Company: New York.Asch, Ricardo H., Weckstein, Louis N., Balmaceda, Jose P., Rojas,Francisco, Spitz, Irving M. and Tadir, Yona. (1990). Case Report.Non-surgical expulsion of non-viable pregnancy: a new applicationof RU 486. Human Reproduction 5 (4): 481–483.Atrash, Hani, Lawson, Herschel W. and Smith, Jack C. (1990). LegalAbortion in the US: Trends and Mortality. Contemporary OB/GYN(February): 58–69.Aubeny, Elisabeth. (1990). New Perspectives for Patients: DrugInduced Abortion by RU 486 and Prostaglandins. Paperpresented at UNFPA-WHO/EURO-IPPF-Zhordania InstituteFrom Abortion to Contraception, Tbilsi, 10–13 October: 1–7.Bardon, Sylvie, Vignon, Françoise, Chalbos, Dany and Rochefort,Henri. (1985). RU 486, a progestin and glucocorticoid antagonist,inhibits the growth of breast cancer cells via the progesteronereceptor. Journal of Clinical Endocrinology and Metabolism 60:692–697.Bart, Pauline. (1987). Seizing the Means of Reproduction: An IllegalFeminist Abortion Collective-How and Why it Worked. QualitativeSociology 10 (4): 339–357.Baulieu, Etienne-Emile and Segal, Sheldon (Eds.). (1985). TheAntiprogestin Steroid RU 486 and Human Fertility Control PlenumPress: New York.Baulieu, Etienne-Emile. (1985). RU 486: An Antiprogestin Steroidwith Contragestive Activity in Women. In: Baulieu, Etienne-Emile132
Page 2 and 3:
Renate Klein is Lecturer in Women
Page 4 and 5:
RU 486Misconceptions,Myths and Mora
Page 6 and 7:
ACKNOWLEDGEMENTSWe would like to ex
Page 8 and 9:
CONTENTSINTRODUCTION 1CHAPTER ONETh
Page 10 and 11:
INTRODUCTIONInitial euphoria greete
Page 12 and 13:
IntroductionUnfortunately, objectio
Page 14 and 15:
Introductiondo not know or do not a
Page 16 and 17:
Introductionused widely for years a
Page 18 and 19:
CHAPTER ONEThe History of RU 486RU
Page 20 and 21:
The History of RU 486consultants ar
Page 22 and 23:
The History of RU 486Events in Fran
Page 24 and 25:
The History of RU 486service of wom
Page 26 and 27:
The History of RU 486The result app
Page 28 and 29:
The History of RU 486developing cou
Page 30 and 31:
The History of RU 486University Hos
Page 32 and 33:
The History of RU 486pharmacovigila
Page 34 and 35:
CHAPTER TWOClaims for RU 486/PG Abo
Page 36 and 37:
Claims for RU 486/PG Abortionsevera
Page 38 and 39:
Claims for RU 486/PG Abortionthe Br
Page 40 and 41:
Claims for RU 486/PG Abortionan imm
Page 42 and 43:
Claims for RU 486/PG Abortionby the
Page 44 and 45:
Claims for RU 486/PG Abortionby the
Page 46 and 47:
Claims for RU 486/PG Abortionfrom A
Page 48 and 49:
Claims for RU 486/PG Abortioncommen
Page 50 and 51:
Claims for RU 486/PG AbortionSome s
Page 52 and 53:
Claims for RU 486/PG Abortionbreeze
Page 54 and 55:
Claims for RU 486/PG Abortion18 per
Page 56 and 57:
Claims for RU 486/PG Abortion1. RU
Page 58 and 59:
Claims for RU 486/PG AbortionRU 486
Page 60 and 61:
Claims for RU 486/PG Abortionwider
Page 62 and 63:
Claims for RU 486/PG Abortionmedica
Page 64 and 65:
Claims for RU 486/PG Abortionreligi
Page 66 and 67:
What Is RU 486 and How Does It Work
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 90 and 91: The Role of Prostaglandins: Known a
Page 122 and 123: ConclusionInstead, Baulieu uses the
Page 124 and 125: Conclusionintervention. Thus, RU 48
Page 126 and 127: Conclusionbetween population contro
Page 128 and 129: ConclusionThis article, appearing i
Page 130 and 131: Conclusion‘a whole net of relatio
Page 132 and 133: ENDNOTESChapter One1The paten t lic
Page 134 and 135: Endnotes12The Journal Officiel publ
Page 136 and 137: Endnotesin Gynecology and Obstetric
Page 138 and 139: Endnotesof menses. On the third day
Page 142 and 143: Bibliographyand Segal, Sheldon (Eds
Page 144 and 145: Bibliographyprostaglandin F 2•. A
Page 146 and 147: BibliographyDelaney, Anne. (1991, 2
Page 148 and 149: Bibliographyresponses to the steroi
Page 150 and 151: Bibliographyabnormalities resulting
Page 152 and 153: Bibliographyprogesterone receptor b
Page 154 and 155: BibliographyOdlind, Viveca and Birg
Page 156 and 157: BibliographyBinding of the anti-pro
Page 158 and 159: BibliographyUlmann, André, Teutsch
Page 160: Bibliographytermination by vacuum a
show all

Ru 486 Misconceptions Myths and Morals - ressourcesfeministes

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?